Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 USD | +0.96% | +0.64% | -88.01% |
May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.01% | 18.19M | |
+11.40% | 115B | |
+12.72% | 106B | |
-4.32% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-12.50% | 17.56B | |
-40.50% | 17.32B | |
+7.32% | 14.03B | |
+32.56% | 12.13B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- Sector Update: Health Care Stocks Higher in Late Afternoon Trading